Literature DB >> 26275350

The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.

Paulina Carmona-Mora1, Jocelyn Widagdo2, Florence Tomasetig1, Cesar P Canales1, Yeojoon Cha1, Wei Lee1, Abdullah Alshawaf3, Mirella Dottori3, Renee M Whan4, Edna C Hardeman1, Stephen J Palmer5.   

Abstract

GTF2IRD1 is one of the three members of the GTF2I gene family, clustered on chromosome 7 within a 1.8 Mb region that is prone to duplications and deletions in humans. Hemizygous deletions cause Williams-Beuren syndrome (WBS) and duplications cause WBS duplication syndrome. These copy number variations disturb a variety of developmental systems and neurological functions. Human mapping data and analyses of knockout mice show that GTF2IRD1 and GTF2I underpin the craniofacial abnormalities, mental retardation, visuospatial deficits and hypersociability of WBS. However, the cellular role of the GTF2IRD1 protein is poorly understood due to its very low abundance and a paucity of reagents. Here, for the first time, we show that endogenous GTF2IRD1 has a punctate pattern in the nuclei of cultured human cell lines and neurons. To probe the functional relationships of GTF2IRD1 in an unbiased manner, yeast two-hybrid libraries were screened, isolating 38 novel interaction partners, which were validated in mammalian cell lines. These relationships illustrate GTF2IRD1 function, as the isolated partners are mostly involved in chromatin modification and transcriptional regulation, whilst others indicate an unexpected role in connection with the primary cilium. Mapping of the sites of protein interaction also indicates key features regarding the evolution of the GTF2IRD1 protein. These data provide a visual and molecular basis for GTF2IRD1 nuclear function that will lead to an understanding of its role in brain, behaviour and human disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26275350     DOI: 10.1007/s00439-015-1591-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  59 in total

1.  An FF domain-dependent protein interaction mediates a signaling pathway for growth factor-induced gene expression.

Authors:  Wei Jiang; Raffaella Sordella; Guang-Chao Chen; Shweta Hakre; Ananda L Roy; Jeffrey Settleman
Journal:  Mol Cell       Date:  2005-01-07       Impact factor: 17.970

Review 2.  Gene silencing and Polycomb group proteins: an overview of their structure, mechanisms and phylogenetics.

Authors:  Shahram Golbabapour; Nazia Abdul Majid; Pouya Hassandarvish; Maryam Hajrezaie; Mahmood Ameen Abdulla; A Hamid A Hadi
Journal:  OMICS       Date:  2013-06

3.  A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.

Authors:  L A Pérez Jurado; Y K Wang; R Peoples; A Coloma; J Cruces; U Francke
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

Review 4.  Copy number variants at Williams-Beuren syndrome 7q11.23 region.

Authors:  Giuseppe Merla; Nicola Brunetti-Pierri; Lucia Micale; Carmela Fusco
Journal:  Hum Genet       Date:  2010-05-01       Impact factor: 4.132

5.  A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.

Authors:  M Tassabehji; M Carette; C Wilmot; D Donnai; A P Read; K Metcalfe
Journal:  Eur J Hum Genet       Date:  1999 Oct-Nov       Impact factor: 4.246

6.  Vascular endothelial growth factor receptor-2: counter-regulation by the transcription factors, TFII-I and TFII-IRD1.

Authors:  Tanisha A Jackson; Harry E Taylor; Deva Sharma; Stephen Desiderio; Sonye K Danoff
Journal:  J Biol Chem       Date:  2005-06-07       Impact factor: 5.157

7.  Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.

Authors:  Tomasz Schneider; Zara Skitt; Yiwen Liu; Robert M J Deacon; Jonathan Flint; Annette Karmiloff-Smith; J Nick P Rawlins; May Tassabehji
Journal:  Behav Brain Res       Date:  2012-05-28       Impact factor: 3.332

8.  Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.

Authors:  Stephen J Palmer; Nicole Santucci; Jocelyn Widagdo; Sara J Bontempo; Kylie M Taylor; Enoch S E Tay; Jeff Hook; Frances Lemckert; Peter W Gunning; Edna C Hardeman
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

9.  The Eutherian Armcx genes regulate mitochondrial trafficking in neurons and interact with Miro and Trak2.

Authors:  Guillermo López-Doménech; Román Serrat; Serena Mirra; Salvatore D'Aniello; Ildiko Somorjai; Alba Abad; Nathalia Vitureira; Elena García-Arumí; María Teresa Alonso; Macarena Rodriguez-Prados; Ferran Burgaya; Antoni L Andreu; Javier García-Sancho; Ramón Trullas; Jordi Garcia-Fernàndez; Eduardo Soriano
Journal:  Nat Commun       Date:  2012-05-08       Impact factor: 14.919

10.  The function of plakophilin 1 in desmosome assembly and actin filament organization.

Authors:  M Hatzfeld; C Haffner; K Schulze; U Vinzens
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

View more
  8 in total

1.  Identification of GdRFC1 as a novel regulator of telomerase in Giardia duodenalis.

Authors:  Xianhe Li; Nan Zhang; Na Wu; Jianhua Li; Ju Yang; Yanhui Yu; Jingtong Zheng; Xin Li; Xiaocen Wang; Pengtao Gong; Xichen Zhang
Journal:  Parasitol Res       Date:  2020-02-19       Impact factor: 2.289

2.  Functions of Gtf2i and Gtf2ird1 in the developing brain: transcription, DNA binding and long-term behavioral consequences.

Authors:  Nathan D Kopp; Kayla R Nygaard; Yating Liu; Katherine B McCullough; Susan E Maloney; Harrison W Gabel; Joseph D Dougherty
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

3.  Williams Syndrome neuroanatomical score associates with GTF2IRD1 in large-scale magnetic resonance imaging cohorts: a proof of concept for multivariate endophenotypes.

Authors:  Chun Chieh Fan; Andrew J Schork; Timothy T Brown; Barbara E Spencer; Natacha Akshoomoff; Chi-Hua Chen; Joshua M Kuperman; Donald J Hagler; Vidar M Steen; Stephanie Le Hellard; Asta Kristine Håberg; Thomas Espeseth; Ole A Andreassen; Anders M Dale; Terry L Jernigan; Eric Halgren
Journal:  Transl Psychiatry       Date:  2018-06-08       Impact factor: 6.222

4.  Syntaxins 6 and 8 facilitate tau into secretory pathways.

Authors:  Wei Siang Lee; Daniel Cs Tan; Yuanyuan Deng; Annika van Hummel; Stefania Ippati; Claire Stevens; Paulina Carmona-Mora; Daryl Ariawan; Liming Hou; Holly Stefen; Tamara Tomanic; Florence Tomasetig; Adam Martin; Thomas Fath; Stephen Palmer; Yazi D Ke; Lars M Ittner; Mian Bi
Journal:  Biochem J       Date:  2021-04-16       Impact factor: 3.857

5.  Gtf2ird1-Dependent Mohawk Expression Regulates Mechanosensing Properties of the Tendon.

Authors:  Tomohiro Kayama; Masaki Mori; Yoshiaki Ito; Takahide Matsushima; Ryo Nakamichi; Hidetsugu Suzuki; Shizuko Ichinose; Mitsuru Saito; Keishi Marumo; Hiroshi Asahara
Journal:  Mol Cell Biol       Date:  2016-03-31       Impact factor: 4.272

6.  RNA-Seq analysis of Gtf2ird1 knockout epidermal tissue provides potential insights into molecular mechanisms underpinning Williams-Beuren syndrome.

Authors:  Susan M Corley; Cesar P Canales; Paulina Carmona-Mora; Veronica Mendoza-Reinosa; Annemiek Beverdam; Edna C Hardeman; Marc R Wilkins; Stephen J Palmer
Journal:  BMC Genomics       Date:  2016-06-13       Impact factor: 3.969

7.  LAMP-2 is required for incorporating syntaxin-17 into autophagosomes and for their fusion with lysosomes.

Authors:  Virginie Hubert; Andrea Peschel; Brigitte Langer; Marion Gröger; Andrew Rees; Renate Kain
Journal:  Biol Open       Date:  2016-10-15       Impact factor: 2.422

8.  Association of GTF2I gene polymorphisms with renal involvement of systemic lupus erythematosus in a Chinese population.

Authors:  Yanming Meng; Yao He; Junlong Zhang; Qibing Xie; Min Yang; Yuning Chen; Yongkang Wu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.